Bayer HealthCare

Top Story

Groundbreaking parasite protection in cats and dogs

With Seresto® Bayer Animal Health launched the first new treatment in more than a decade to offer combined tick and flea protection for both cats and dogs. The anti-parasite collar provides outstanding protection for up to eight months from a single application. As the first product to offer repellency against ticks for cats as well as dogs, Seresto® also helps to reduce the risk of vector-borne disease transmission from these parasites. Seresto® provides groundbreaking parasite protection in cats and dogs

Going to great lengths

Extreme freeride snowboarder Chris Southwell is sure of one thing: Life is about challenges. And this one has been his biggest yet. The 29-year-old Briton, who had been diagnosed with type 1 diabetes seven years ago, recently competed in his first triathlon competition. more

Exercising prevents hemorrhoidal problems

Almost every other person over the age of 50 knows hemorrhoidal problems. An enlargement of the vascular cushions at the end of the rectum can cause itching, pain, swelling, and bleeding. Physical activity is highly recommended as a means of preventing the disease. It reduces the blood pressure in the hemorroidal plexus that causes the annoying symptoms. The information service on www.hemorrhoid-help.com provides answers to the most frequently asked questions about the disease. more

Renal cancer: Early diagnosis can save lives

In Germany, some 6,400 women and 10,000 men are newly diagnosed with kidney cancer each year. Worldwide, annually, the rate of new cases is over 20,000. More than 85 percent of kidney cancers are renal cell carcinomas. The malignant tumor forms directly from damaged kidney cells and is insidious and difficult to treat. more

New guidelines for the prevention of stroke and heart attack

Cardiovascular disease (CVD) is the number one cause of death around the world. The processes that lead to CVD begin during childhood and progress throughout life. If an individual lives in a healthy way, does not smoke, and exercises regularly, the subsequent risk of cardiovascular disease can be reduced. The World Heart Federation focusses in its current newsletter on two guidelines for primordial and secondary prevention. Furthermore, the News Brief provides links to events such as the World Congress of Cardiology Scientific Sessions 2012 in Dubai. more

Newsroom Thrombosis

Thrombosis occurs mainly in the legs, for example after long surgeries. Also cardiac arrhythmias like atrial fibrillation can cause this serious occlusion of a blood vessel too and lead to dangerous diseases like stroke. This newsroom bundles all articles and detailed background information concerning thrombosis. more

Webcasts ”New Treatment Options for Retinal Diseases”

At the end of 2010, a Bayer Schering Pharma media event entitled “New Treatment Options for Retinal Diseases” took place in Vienna, Austria. Renowned experts presented background material on VEGF Trap-Eye, a new solution for the treatment of retinal diseases like Wet AMD, which is the leading cause of acquired blindness in the elderly. Videos and all presentations from the event are available as on-demand webcasts in the viva.vita Webcast-Center. more

Interactive journey for the launch of Levitra® 10 mg orodispersible tablet

Bayer HealthCare Pharmaceuticals introduced the Levitra® 10 mg orodispersible tablet for the treatment of erectile dysfunction (ED) at the Men’s Health World Congress 2010. A moderated, virtual tour now offers all press material and videos for download. With a few clicks the journey begins … more

Aspirin® Cardio Journalist Workshop

In Europe, more than four million people die from cardiovascular diseases each year – and the burden is set to increase. The World Health Organization (WHO) predicts that the number of deaths will reach approximately 23.6 million by 2030 globally. At the Aspirin® Cardio Journalist Workshop 2011, which took place in Bitterfeld, Germany, leading experts discussed the benefits of low-dose acetylsalicylic acid, the active ingredient of Aspirin®, in the prevention of heart attack and stroke. more

The miracle drug

Verdi’s famous opera La traviata and Aspirin® have one thing in common: both of them had their first major appearance on March 6. Giuseppe Verdi celebrated the premiere of his masterpiece in Venice in 1853, while Bayer’s Aspirin® brand was registered under number 36433 in the list of trade names at the Imperial Patent Office in Berlin in 1899. While the opera initially flopped and only later brought its composer fame and fortune, the drug of the century went from strength to strength from the very first day and celebrated an unparalleled career. more

Healthcare News
Events
Service Material

Healthcare News

2012-05-16 | Worldnews Bayer to Present Data on Late-Stage Development Oncology Compounds at ASCO 2012

2012-05-16 | Worldnews
Bayer to Present Data on Late-Stage Development Oncology Compounds at ASCO 2012

First data from Phase III trial for regorafenib in gastrointestinal tumors (GIST) presented as Late-Breaking Abstract in Oral Abstract Session / Updated survival results from Phase III trial for Alpharadin (radium-223 chloride) in castration-resistant prostate cancer (CRPC) presented as Late-Breaking Abstract in Oral Abstract Session more
2012-05-10 | Worldnews "Lebenstagebuch" wins Aspirin Social Award 2012

2012-05-10 | Worldnews
"Lebenstagebuch" wins Aspirin Social Award 2012

Berlin institution offers traumatized children of the Second World War unique writing therapy / 2nd place: Ärzte-Netzwerk Berlin (network of physicians in Berlin): Medical care for homeless people / 3rd place: REBOUND: Heidelberg drug prevention program for school students / Bayer Board of Management member Dr. Pott at award ceremony at Humboldt University in Berlin: "Innovative social initiatives with valuable contributions to health care" more
2012-05-09 | Worldnews Bayer’s Xarelto® (Rivaroxaban) Submitted to U.S. FDA to Reduce the Risk of Stent Thrombosis in Patients with Acute Coronary Syndrome

2012-05-09 | Worldnews
Bayer’s Xarelto® (Rivaroxaban) Submitted to U.S. FDA to Reduce the Risk of Stent Thrombosis in Patients with Acute Coronary Syndrome

Bayer’s cooperation partner, Janssen Research & Development, LLC has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration seeking approval for the use of Xarelto® (rivaroxaban) 2.5 mg BID to reduce the risk of stent thrombosis in patients with Acute Coronary Syndrome (ACS). more

More news

Events

World Hypertension Day on May 17, 2012

With its theme "Healthy Lifestyle – Healthy Blood Pressure", the World Hypertension Day draws attention to the impact of nutrition and exercision for the cardiovascular system. The lack of knowledge among hypertensive patients and physicians alike should be compensated by the awareness day supported by the World Health Organization. more
21st European Stroke Conference, May 22-25, 2012

The European Stroke Conference is the most important meeting in the field of cerebrovascular diseases. The 21st edition takes place in Lisbon. Scientists and physicians from all over the world exchange their opinions and hold presentations about the progress in MRI-technology and stroke prevention. more
Annual Meeting of the American Society of Clinical Oncology, June 1-5, 2012

The Annual Meeting of the American Society of Clinical Oncology (ASCO) brings together more than 25,000 oncology professionals from a broad range of specialties. This year the two main topics are breast cancer and CNS tumors. Cancerous cells in the brain or the spinal cord are one of the most common forms of cancer among children. The ASCO Meeting gives an overview about treatment and prevention possibilities. more

event calendar

Service Material

Avoiding colds and flues

As the winter months approach, the chance for catching a flu or a cold increases. It is estimated that adults will suffer the disease two to five times a year. Children are even more likely to catch a cold. The increased incidence during the cold season may be attributed to the fact that cold viruses thrive in low humidity, making the nasal passages drier and more vulnerable to infection. Read more about the most frequent disease of all time on the Aspirin website. more
New edition of research, the Bayer scientific magazine

Personalized medicine, the battle against malaria and a seismic wallpaper are the main topics covered by the 23rd edition of “research”. The magazine further encloses articles on popular scientific findings concerning all aspects of research at Bayer. It gives an insight into Bayer’s laboratories and portraits the people involved. Expert interviews and essays from external and internal scientists additionally complete the package. more
MRI for children – comic and picture books help to understand

A new extension of approval by the authorities allows magnetic resonance imaging (MRI) to be used in children over the age of seven in many European countries. To create an MRI image, patients have to lie inside a scanner and keep still for up to 20 minutes – a challenge, especially for children and adolescents. Bayer Schering Pharma supports physicians, parents, and children by providing them with age-appropriate information about the procedure. You can find a picture book here, and a comic book here. more